Seroepidemiology of hepatitis A virus in Kuwait

World Journal of Gastroenterology

Volumn 15, Issue 1, 2009, Pages 102-105

  Alkhalidi, Jameela ^a   Alenezi, Bader ^a   Al Mufti, Seham ^a   Hussain, Entisar ^a   Askar, Haifa ^a   Kemmer, Nyingi ^b   Neff, Guy W ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Fulminant liver failure; Hepatitis A virus; Hepatitis A virus vaccine; Kuwait

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN G;

ADULT; AGE DISTRIBUTION; ARTICLE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HEALTH CARE NEED; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; KUWAIT; MAJOR CLINICAL STUDY; MALE; PARENT; POPULATION RESEARCH; PREVALENCE; SEROEPIDEMIOLOGY; SINGLE PARENT;

EID: 59249086629     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.102     Document Type: Article

References (22)

1. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, Ferraro T, Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338: 286-290
2. Nordenfelt E, Atack W, Al-Kandani S, Al-Nakib W. Hepatitis A in Kuwait. J Kuwait Med Assoc 1985; 19: 103-108
3. Feinstone SM, Kapikian AZ, Purceli RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 1973; 182: 1026-1028
4. Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med 1985; 313: 1059-1067
5. Cohen JI, Feinstone S, Purcell RH. Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J Infect Dis 1989; 160: 887-890
6. Costa-Mattioli M, Monpoeho S, Nicand E, Aleman MH, Billaudel S, Ferre V. Quantification and duration of viraemia during hepatitis A infection as determined by real-time RTPCR. J Viral Hepat 2002; 9: 101-106
7. Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am 2000; 14: 605-615
8. Husain E, Husain K. Hepatitis A injection in children in Kuwait. Epidemiology and clinical features 41st Annual meeting of the infectious diseases society of America; 2003 Oct 9-12; San Diego, California
9. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000; 18 Suppl 1: S65-S67
10. Fathalla SE, Al-Jama AA, Al-Sheikh IH, Islam SI. Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia. Saudi Med J 2000; 21: 945-949
11. Dajani A, Boloushi S, Kashkosh A. HAV: The risk in UAE. A shift of epidemicity may improve future concern, 3rd Emirates gastroenterology conference. 1995; Dubai, United Arab Emirates
12. Barzaga BN. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine 2000; 18 Suppl 1: S61-S64
13. Wang SM, Liu CC, Huang YS, Yang YJ, Lei HY. Change in hepatitis A virus seroepidemiology in southern Taiwan: a large percentage of the population lack protective antibody. J Med Virol 2001; 64: 104-108
14. Das K, Jain A, Gupta S, Kapoor S, Gupta RK, Chakravorty A, Kar P. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol 2000; 16: 507-510
15. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000; 18 Suppl 1: S57-S60
16. Moschen ME, Floreani A, Zamparo E, Baldo V, Majori S, Gasparini V, Trivello R. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy. Eur J Epidemiol 1997; 13: 875-878
17. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1996; 45: 1-36
18. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327: 453-457
19. Wiedermann G, Kundi M, Ambrosch F, Safary A, D'Hondt E, Delem A. Inactivated hepatitis A vaccine: long-term antibody persistence. Vaccine 1997; 15: 612-615
20. Averhoff F, Shapiro CN, Bell BP, Hyams I, Burd L, Deladisma A, Simard EP, Nalin D, Kuter B, Ward C, Lundberg M, Smith N, Margolis HS. Control of hepatitis A through routine vaccination of children. JAMA 2001; 286: 2968-2973
21. Werzberger A, Mensch B, Nalin DR, Kuter BJ. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years followup after the Monroe field trial of VAQTA. Vaccine 2002; 20: 1699-1701
22. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51: 1-78